Bio-Techne Corp.
Kim Kelderman (Chief Executive Officer) reports TECH insider transactions
About this filing
Bio-Techne Corp. (TECH) filed Form 4/A (insider transaction (amendment)) with the SEC on Nov 2, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Kim Kelderman · Chief Executive Officer, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Aug 15, 2026 | M · exercise or conversion of a derivative | +21,736 | $0.00 | $0.00 | 93,849 | Direct |
| Aug 15, 2026 | F · tax withholding | −10,955 | $72.40 | $793,142.00 | 82,894 | Direct |
| Aug 15, 2026 | D · sale back to the companyPerformance Stock Options (Right to Buy)Footnotes F1 | −22,044 | $0.00 | $0.00 | 1,837 | Direct |
| Aug 15, 2026 | D · sale back to the companyPerformance Stock Options (Right to Buy)Footnotes F2 | −23,949 | $0.00 | $0.00 | 1,996 | Direct |
| Aug 15, 2026 | M · exercise or conversion of a derivativePerformance Restricted Stock UnitsFootnotes F3, F4 | −683 | $0.00 | $0.00 | 8,190 | Direct |
| Aug 15, 2026 | D · sale back to the companyPerformance Restricted Stock UnitsFootnotes F3, F4 | −8,190 | $0.00 | $0.00 | 0 | Direct |
| Aug 15, 2026 | M · exercise or conversion of a derivativePerformance Restricted Stock UnitsFootnotes F3, F5 | −725 | $0.00 | $0.00 | 8,698 | Direct |
| Aug 15, 2026 | D · sale back to the companyPerformance Restricted Stock UnitsFootnotes F3, F5 | −8,698 | $0.00 | $0.00 | 0 | Direct |
| Aug 15, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F3, F6 | −8,543 | $0.00 | $0.00 | 8,544 | Direct |
| Aug 15, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F3, F7 | −11,785 | $0.00 | $0.00 | 23,569 | Direct |
Footnotes
- F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited.
- F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited.
- F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited.
- F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited.
- F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
- F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
More TECH filings
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4/A
Filed Nov 2, 2026
- 4/A
Filed Nov 2, 2026
- 4/A
Filed Nov 2, 2026
- 4
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.